Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 48:1-9, January-February
doi: 10.1176/appi.psy.48.1.1
© 2007 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Looper, K. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Looper, K. J.
Related Collections
* Primary Care
* Depression
* Syndromes Secondary to General Medical Disorders
* Antidepressants

Review

Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications

Karl J. Looper, M.D.

Received January 4, 2006; revised July 14, 2006; accepted July 26, 2006. From the Dept. of Psychiatry, McGill University, Montreal, Canada and the Consultation–Liaison Service, Dept. of Psychiatry, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada. Send correspondence and reprint requests to Karl Looper, M.D., Sir Mortimer B. Davis Jewish General Hospital, Office A-540, 3755 Chemin de la Côte-Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada. e-mail: karl.looper{at}mcgill.ca

Serotonergic antidepressants are the most widely used group of antidepressant medications. Although generally considered to have a favorable adverse-effect profile, serotonergic antidepressants are associated with potentially dangerous medical complications, some of which have only recently become apparent to patients and clinicians. This article reviews the association of serotonergic antidepressants and the following medical complications: syndrome of inappropriate antidiuretic hormone secretion, bleeding, serotonin syndrome, serotonin-discontinuation syndrome, and adverse pregnancy and neonatal effects. Physicians need to remain aware of these potential medical complications and integrate this information into their clinical decision-making, informed-consent process, baseline assessment, and follow-up monitoring.







Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org